Pathway Genomics is jumping into the direct-to-consumer genetic testing market, reports Agence France Presse. According to the company website, the health test costs $249 and will genotype customers for risk markers for over 90 diseases, carrier status for some diseases, drug responses, and inheritable traits (such as eye color), while the ancestry test is $199, though both can be purchased simultaneously for $348. Pathway Genomics will also have genetic counselors on staff. "Our goal is to keep a low cost and make this test available to anyone," founder and CEO Jim Plante tells AFP. "I always felt that consumers didn't have direct access to genetic information in a way that was cost effective."
One More Enters the Fray
Jul 15, 2009